ES2058601T3 - Formulaciones que contienen heparina. - Google Patents

Formulaciones que contienen heparina.

Info

Publication number
ES2058601T3
ES2058601T3 ES89904849T ES89904849T ES2058601T3 ES 2058601 T3 ES2058601 T3 ES 2058601T3 ES 89904849 T ES89904849 T ES 89904849T ES 89904849 T ES89904849 T ES 89904849T ES 2058601 T3 ES2058601 T3 ES 2058601T3
Authority
ES
Spain
Prior art keywords
formulations containing
containing heparin
heparin
endobeta
glucuronidase
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES89904849T
Other languages
English (en)
Inventor
Roy Sawyer
Christopher Powell-Jones
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Patent GmbH
Original Assignee
Merck Patent GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent GmbH filed Critical Merck Patent GmbH
Application granted granted Critical
Publication of ES2058601T3 publication Critical patent/ES2058601T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/49—Urokinase; Tissue plasminogen activator
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/57—Protease inhibitors from animals; from humans
    • A61K38/58—Protease inhibitors from animals; from humans from leeches, e.g. hirudin, eglin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biomedical Technology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Una formulación farmacéutica que comprende heparina en combinación con una endobeta-glucuronidasa.
ES89904849T 1988-04-14 1989-04-14 Formulaciones que contienen heparina. Expired - Lifetime ES2058601T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB888808810A GB8808810D0 (en) 1988-04-14 1988-04-14 Heparin-containing formulations

Publications (1)

Publication Number Publication Date
ES2058601T3 true ES2058601T3 (es) 1994-11-01

Family

ID=10635179

Family Applications (1)

Application Number Title Priority Date Filing Date
ES89904849T Expired - Lifetime ES2058601T3 (es) 1988-04-14 1989-04-14 Formulaciones que contienen heparina.

Country Status (7)

Country Link
EP (2) EP0440625B1 (es)
JP (1) JP2783367B2 (es)
AU (1) AU632482B2 (es)
DE (1) DE68908716T2 (es)
ES (1) ES2058601T3 (es)
GB (1) GB8808810D0 (es)
WO (1) WO1989009615A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0487660B1 (en) * 1990-04-06 1997-08-20 MERCK PATENT GmbH Treatment of thrombotic events
SE9301581D0 (sv) * 1993-05-07 1993-05-07 Kabi Pharmacia Ab Protein formulation
CU23203A1 (es) * 2002-12-27 2007-05-18 Ct Ingenieria Genetica Biotech Formulaciones que contienen agentes de accion trombolitica para su administracion por via rectal
WO2007038749A2 (en) 2005-09-28 2007-04-05 Biovascular, Inc. Methods and compositions for blocking platelet and cell adhesion, cell migration and inflammation

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8504025D0 (en) * 1985-02-16 1985-03-20 Biopharm Ltd Hyaluronidase
IL79254A0 (en) * 1986-06-26 1986-09-30 Hadassah Med Org Compositions for preventing graft rejection
US4879282A (en) * 1987-03-17 1989-11-07 Saliba Jr Michael J Medical application for heparin and related molecules

Also Published As

Publication number Publication date
JPH03503644A (ja) 1991-08-15
GB8808810D0 (en) 1988-05-18
DE68908716D1 (de) 1993-09-30
JP2783367B2 (ja) 1998-08-06
EP0340933A2 (en) 1989-11-08
EP0440625B1 (en) 1993-08-25
WO1989009615A1 (en) 1989-10-19
AU3444589A (en) 1989-11-03
AU632482B2 (en) 1993-01-07
EP0340933A3 (en) 1990-03-28
EP0440625A1 (en) 1991-08-14
DE68908716T2 (de) 1994-07-14

Similar Documents

Publication Publication Date Title
MX9203480A (es) Formulaciones medicinales en aereosol.
MX9306499A (es) Composiciones farmaceuticas que contienen una anfetamina.
ATE98480T1 (de) Arzneimittelformulierungen.
DE68901417D1 (de) Pharmazeutische zusammensetzung.
FR2631232B1 (fr) Adsorbats medicamenteux
MX9205345A (es) Alquil-bisacilfosfinoxidos y composicion que contienen los mismos.
MX9202546A (es) Dimeros de rapamicina y composicion farmaceutica que los contiene.
IT8819179A0 (it) Dispositivo di emodiafiltrazione erelativo procedimento di emodiafiltrazione.
DE3480599D1 (de) 1-hydroxypyrid-2-on-derivate enthaltende pharmazeutische zubereitungen.
NO890505L (no) Vandig blekepreparat.
AU6871587A (en) Verapamil dosage form
DE68918847D1 (de) Stabile pharmazeutische zusammensetzung.
DE3882157D1 (de) Nichtsteroide antientzuendungswirkstoffe enthaltende pharmazeutische zubereitungen.
DE68908650D1 (de) Dynamisch wahlfreie Speichereinrichtung.
ES2012045B3 (es) Derivados amidicos y medicamentos de uso externo que los contienen.
ES2058601T3 (es) Formulaciones que contienen heparina.
NO894895D0 (no) Flammehemmende preparater.
DE68918921D1 (de) Verbesserungen an Stühlen.
DE68906734D1 (de) Dentaler laser.
ES2093779T3 (es) Formulacion farmaceutica que contiene diritromicina.
MX9203632A (es) Derivados de cicloalquiltiazol y composiciones farmaceuticas que los contienen.
ES1008532Y (es) Mueble que comprende una base dotada con ruedas orientables.
DE3866789D1 (de) Pharmazeutische zusammensetzungen.
FI894072A (fi) Polypeptider anvaendbara som vaccin.
DE68915929D1 (de) Optischer Isolator.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 440625

Country of ref document: ES